Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Disease Models & Mechanisms|August 14, 2012
A yeast model for amyloid-β aggregation exemplifies the role of membrane trafficking and PICALM in cytotoxicityFabien D'Angelo, Hélène Vignaud, Julie Di Martino, et al.
The EMBO Journal|February 28, 2003
Internal initiation drives the synthesis of Ure2 protein lacking the prion domain and affects [URE3] propagation in yeast cellsAnton A Komar, Thierry Lesnik, Christophe Cullin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 21, 2009
Driving amyloid toxicity in a yeast model by structural changes: a molecular approachKarine Berthelot, Françoise Immel, Julie Géan, et al.
The Journal of Biological Chemistry|January 20, 2007
In vitro analysis of SpUre2p, a prion-related protein, exemplifies the relationship between amyloid and prionFrancoise Immel, Yi Jiang, Yi-Qian Wang, et al.
International Journal of Biological Macromolecules|April 3, 2021
β-Amyloid peptide interactions with biomimetic membranes: A multiparametric characterizationWilly Smeralda, Marc Since, Julien Cardin, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 4, 2015
Yeast as a Model for Alzheimer's Disease: Latest Studies and Advanced StrategiesMathias Verduyckt, Hélène Vignaud, Tine Bynens, et al.
EMBO Reports|December 26, 2001
The [URE3] phenotype: evidence for a soluble prion in yeastEric Fernandez-Bellot, Elisabeth Guillemet, Frederique Ness, et al.
Angewandte Chemie (International Ed. in English)|October 3, 2018
PIP<sub>2</sub> Phospholipid-Induced Aggregation of Tau Filaments Probed by Tip-Enhanced Raman SpectroscopyDavid Talaga, Willy Smeralda, Laurie Lescos, et al.
Frontiers in Molecular Neuroscience|November 21, 2018
The Impact of ESCRT on Aβ<sub>1-42</sub> Induced Membrane Lesions in a Yeast Model for Alzheimer's DiseaseGernot Fruhmann, Christelle Marchal, Hélène Vignaud, et al.
Pageof 5